GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Fasn | decreases expression | EXP | | 6480464 | CTD | Valproic Acid results in decreased expression of FASN mRNA | PMID:19224547 | Fasn | affects expression | ISO | Fasn (Mus musculus) | 6480464 | CTD | Valproic Acid affects the expression of FASN mRNA | PMID:17292431 | Fasn | decreases expression | ISO | FASN (Homo sapiens) | 6480464 | CTD | Valproic Acid results in decreased expression of FASN mRNA | PMID:23179753 PMID:26272509 PMID:28001369 PMID:29501571 PMID:33901630 | Fasn | decreases expression | ISO | Fasn (Mus musculus) | 6480464 | CTD | Valproic Acid results in decreased expression of FASN mRNA | PMID:19136453 PMID:21427059 | Fasn | increases expression | ISO | FASN (Homo sapiens) | 6480464 | CTD | Valproic Acid results in increased expression of FASN mRNA; Valproic Acid results in increased expression of FASN protein | PMID:25716160 PMID:30003287 | Fasn | increases expression | ISO | Fasn (Mus musculus) | 6480464 | CTD | Valproic Acid results in increased expression of FASN mRNA | PMID:15345369 PMID:21427059 | Fasn | multiple interactions | ISO | FASN (Homo sapiens) | 6480464 | CTD | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FASN mRNA; NR1H3 protein affects the reaction [Valproic Acid results in increased expression of FASN mRNA] | PMID:27188386 PMID:30003287 | |
Go Back to source page | Continue to Ontology report |